Carbaglu Oral Tablet 200Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Carbaglu: Oral tablet (200mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CARGLUMIC ACID is used to lower the amount of ammonia in the blood of patients with N-acetylglutamate synthase deficiency. This medicine is not a cure.

In-Depth Information

Carbaglu 200mg Tablet

NDC: 522760312
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
N-acetylglutamate Synthase Deficiency, Hyperammonemia

Storage Information
Discard opened bottle after 30 days
Store unopened containers in refrigerator (36 to 46 degrees F)
Protect from moisture
Product stored at controlled room temperature should not be returned to a refrigerator
May be stored at room temperature not exceeding 86 degrees F for up to 1 month
Carbaglu 200mg Tablet

Reported Side Effects for Carbaglu 200mg Tablet

Decreased Appetite Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Excessive Sweating Incidence:
9.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
13.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Carbaglu

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5